Daniel G. Hoernschemeyer

Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial

Ravi Savarirayan, Louise Tofts, Melita Irving et al. · The Lancet · 2020 · 184 citations

Subcutaneous Vosoritide Therapy, Pediatrics, Multicentre Trial +2

Anterior Vertebral Body Tethering for Adolescent Scoliosis with Growth Remaining

Daniel G. Hoernschemeyer, Melanie E. Boeyer, Madeline E. Robertson et al. · Journal of Bone and Joint Surgery · 2020 · 162 citations

Effects of dexmedetomidine on intraoperative motor and somatosensory evoked potential monitoring during spinal surgery in adolescents

Joseph D. Tobias, TIMOTHY J. GOBLE, G. WILLIAM BATES et al. · Pediatric Anesthesia · 2008 · 106 citations · Full text

Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study

Ravi Savarirayan, Louise Tofts, Melita Irving et al. · Genetics in Medicine · 2021 · 88 citations · Full text

Effects of dexmedetomidine on propofol and remifentanil infusion rates during total intravenous anesthesia for spine surgery in adolescents

NKANYEZI E. NGWENYAMA, John Anderson, Daniel G. Hoernschemeyer et al. · Pediatric Anesthesia · 2008 · 77 citations · Full text